Maria Gabriella Camboni

Gabriella was co-founder and COO of EOS (Ethical Oncology Science), an Italian start-up dedicated to translational medicine in oncology, until the acquisition of the company by Clovis Oncology in November 2013. Previously, she held various managerial positions in the biotech and pharma industry: she was co-founder and Head of Development at Novuspharma and then Head of Medical Affairs Europe in Novartis Oncology until 2006. Gabriella holds a degree in Medicine from the University of Milan and a specialization in Gastroenterology and Clinical Pharmacology. She is board member at Mission Therapeutics (UK) and Genenta (IT).